Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02465697 · ClinicalTrials.gov registry record · NA
Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT02465697 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 169 participants.
The verdict
NCT02465697, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
Borderline Personality Disorder (BPD), a prevalent psychiatric disorder found in approximately 2% to 6% of the population and 20% of hospitalized psychiatric patients, has proven quite treatment resistant. This study is designed to determine whether patients with BPD can be trained to improve their ability to regulate their emotions and whether this leads to changes in how their brans regulate emotion.
Interventions
- BEHAVIORAL Reappraisal Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02465697
The ClinicalTrials.gov registry entry for NCT02465697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reappraisal Training is the first listed.
NCT02465697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02465697 about?
NCT02465697 is a clinical study titled "Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions". Borderline Personality Disorder (BPD), a prevalent psychiatric disorder found in approximately 2% to 6% of the population and 20% of hospitalized psychiatric patients, has proven quite treatment resistant. This study is designed to determine whether patients with BPD can be trained to improve their ...
What is the current status of trial NCT02465697?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2011-09. Estimated completion is 2017-09-21.
What interventions are being tested in trial NCT02465697?
The interventions under investigation include: Reappraisal Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02465697?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.